Motley Fool Asset Management’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
Sell
-11,792
Closed -$363K 174
2019
Q2
$363K Buy
11,792
+192
+2% +$5.91K 0.04% 153
2019
Q1
$485K Buy
11,600
+1,917
+20% +$80.2K 0.06% 138
2018
Q4
$440K Buy
+9,683
New +$440K 0.06% 132